Company / Current Liabilities per Share
Avalo Therapeutics, Inc. Current Liabilities per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.24
FY2025
5-year range
$0.27 / $117.52
FY2021-FY2025
Trend
-85.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 9 years, ranging from $0.27 in FY2021 to $117.52 in FY2023.
Based on SEC 10-K filings.
1.24 in FY2025 with a 5-year CAGR of +29.2%.
Improved from $117.52 to $1.24 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -19.3%
- 5-Year CAGR
- +29.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 85.8% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.24 | -85.8% |
| FY2024 | $8.68 | -92.6% |
| FY2023 | $117.52 | +4895.3% |
| FY2022 | $2.35 | +787.3% |
| FY2021 | $0.27 | -22.7% |
| FY2020 | $0.34 | +15.1% |
| FY2019 | $0.30 | -64.5% |
| FY2018 | $0.84 | -28.7% |
| FY2017 | $1.18 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026